Prolonged increase in psychotropic drug use among young women following the COVID-19 pandemic: a French nationwide retrospective study.

Autor: Lamer A; Fédération Régionale de Recherche en Psychiatrie Et Santé Mentale - F2RSM Psy, Hauts-de-France, Saint-André-Lez-Lille, France. antoine.lamer@univ-lille.fr.; Univ. Lille, CHU Lille, ULR 2694-METRICS: Évaluation des Technologies de santé et des Pratiques médicales, Lille, France. antoine.lamer@univ-lille.fr., Saint-Dizier C; Fédération Régionale de Recherche en Psychiatrie Et Santé Mentale - F2RSM Psy, Hauts-de-France, Saint-André-Lez-Lille, France.; Univ. Lille, CHU Lille, ULR 2694-METRICS: Évaluation des Technologies de santé et des Pratiques médicales, Lille, France., Levaillant M; Department of Methodology and Biostatistics, CHU Angers, Angers, France., Hamel-Broza JF; Department of Methodology and Biostatistics, CHU Angers, Angers, France.; Inserm, U1085, Irset, équipe ESTER, université d'Angers, faculté de santé, Angers, France., Ayed E; Univ. Lille, CHU Lille, ULR 2694-METRICS: Évaluation des Technologies de santé et des Pratiques médicales, Lille, France., Chazard E; Univ. Lille, CHU Lille, ULR 2694-METRICS: Évaluation des Technologies de santé et des Pratiques médicales, Lille, France., Bubrovszky M; Fédération Régionale de Recherche en Psychiatrie Et Santé Mentale - F2RSM Psy, Hauts-de-France, Saint-André-Lez-Lille, France., D'Hondt F; Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, 59000, France.; Centre National de Ressources Et de Résilience (Cn2r) Lille-Paris, Lille, France., Génin M; Univ. Lille, CHU Lille, ULR 2694-METRICS: Évaluation des Technologies de santé et des Pratiques médicales, Lille, France., Horn M; Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, 59000, France.; Centre National de Ressources Et de Résilience (Cn2r) Lille-Paris, Lille, France.

Publikováno v: BMC medicine [BMC Med] 2024 Jul 02; Vol. 22 (1), pp. 274. Date of Electronic Publication: 2024 Jul 02.

Impact of COVID-19 pandemic and lockdowns on the consumption of anxiolytics, hypnotics and antidepressants according to age groups: a French nationwide study.

Autor: Levaillant M; University of Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France.; Department of Methodology and Biostatistics, CHU Angers, 4 rue Larrey, 49933 Angers, France., Wathelet M; University of Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France.; Centre National de Ressources et de Résilience Lille-Paris (CN2R), F-59000 Lille, France.; Fédération de Recherche en Psychiatrie et Santé Mentale des Hauts-de-France, F-59000 Lille, France., Lamer A; University of Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France., Riquin E; Department of Child and Adolescent Psychiatry, University Hospital of Angers, Angers, France.; Mitovasc Unit, UMR CNRS 6015-INSERM, 1083 Angers, France.; Laboratory of Psychology, LPPL EA4638, University of Angers, Angers, France., Gohier B; Department of Psychiatry and Addictology, Angers University Hospital, Angers, France.; UPRES EA 4638, University of Angers, Angers, France., Hamel-Broza JF; Department of Methodology and Biostatistics, CHU Angers, 4 rue Larrey, 49933 Angers, France.; Inserm, U1085, Irset, équipe ESTER, université d'Angers, faculté de santé, Angers, France.

Publikováno v: Psychological medicine [Psychol Med] 2023 May; Vol. 53 (7), pp. 2861-2867. Date of Electronic Publication: 2021 Dec 20.

Response: Is there still an indication for episiotomy? Results from a French national database analysis.

Autor: Levaillant M; University of Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des Technologies de Santé et des Pratiques Médicales, Lille, France.; Methodology and Biostatistics Department, Angers University Hospital, University of Angers, Angers, France., Loury C; Faculté de Santé, Département de Médecine, Angers, France.; Service de Gynécologie-Obstétrique, CHU d'Angers, Angers, France., Venara A; Faculté de Santé, Département de Médecine, Angers, France.; Service de Chirurgie Digestive, CHU d'Angers, Angers, France., Hamel-Broza JF; Methodology and Biostatistics Department, Angers University Hospital, University of Angers, Angers, France.; Service de Gynécologie-Obstétrique, CHU d'Angers, Angers, France., Legendre G; Faculté de Santé, Département de Médecine, Angers, France.; UMR_S1085, University of Angers, CHU Angers, University of Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), Angers, France.

Publikováno v: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2023 Feb; Vol. 160 (2), pp. 718. Date of Electronic Publication: 2022 Nov 20.

In response to Mayte Bryce-Alberti's letter about "Factors influencing medical students' choice of specialization: A gender based systematic review".

Autor: Levaillant M; Methodologic and biostatistics department, CHU Angers, University Angers, France., Levaillant L; Department of Pediatric Endocrinology and Diabetology, University Hospital of Angers, Angers Cedex 9, France., Hamel-Broza JF; Methodologic and biostatistics department, CHU Angers, University Angers, France.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2021 Jan 06; Vol. 31, pp. 100706. Date of Electronic Publication: 2021 Jan 06 (Print Publication: 2021).

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia.

Autor: Chretien AS; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068; CNRS, UMR7258, Institut Paoli-Calmettes; Aix-Marseille University, UM 105, Marseille, France.; Immunomonitoring platform, Institut Paoli-Calmettes, Marseille, France., Fauriat C; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068; CNRS, UMR7258, Institut Paoli-Calmettes; Aix-Marseille University, UM 105, Marseille, France.; Immunomonitoring platform, Institut Paoli-Calmettes, Marseille, France., Orlanducci F; Immunomonitoring platform, Institut Paoli-Calmettes, Marseille, France., Galseran C; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068; CNRS, UMR7258, Institut Paoli-Calmettes; Aix-Marseille University, UM 105, Marseille, France., Rey J; Hematology Department, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068; CNRS, UMR7258, Institut Paoli-Calmettes; Aix-Marseille University, UM 105, Marseille, France., Bouvier Borg G; Beckman Coulter Immunotech, Marseille, France., Gautherot E; Beckman Coulter Immunotech, Marseille, France., Granjeaud S; Systems Biology Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068; CNRS, UMR7258, Institut Paoli-Calmettes; Aix-Marseille University, UM 105, Marseille, France., Hamel-Broza JF; Biostatistics and methodology department, CHU Angers, Angers, France., Demerle C; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068; CNRS, UMR7258, Institut Paoli-Calmettes; Aix-Marseille University, UM 105, Marseille, France., Ifrah N; Hematology department, CHU Angers, Angers, France., Lacombe C; GOELAMStheque, FILO (French Innovative Leukemia Organization), Cochin Hospital, APHP, Paris, France., Cornillet-Lefebvre P; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Reims, Reims, France., Delaunay J; Service d'Hématologie, Centre Catherine de Sienne, Nantes, France., Toubert A; INSERM UMRS-1160, Univ Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Immunology and Histocompatibility department, Hôpital Saint-Louis, APHP, Paris, France., Gregori E; Centre d'Immunophénomique - CIPHE (PHENOMIN), Aix Marseille University, UMS3367; Inserm US012; CNRS, UMS3367, Marseille, France., Luche H; Centre d'Immunophénomique - CIPHE (PHENOMIN), Aix Marseille University, UMS3367; Inserm US012; CNRS, UMS3367, Marseille, France., Malissen M; Centre d'Immunophénomique - CIPHE (PHENOMIN), Aix Marseille University, UMS3367; Inserm US012; CNRS, UMS3367, Marseille, France.; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Inserm U1104, CNRS UMR7280, F-13288, Marseille, France., Arnoulet C; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068; CNRS, UMR7258, Institut Paoli-Calmettes; Aix-Marseille University, UM 105, Marseille, France.; Biopathology Department, Institut Paoli Calmettes, Marseille, France., Nunes JA; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068; CNRS, UMR7258, Institut Paoli-Calmettes; Aix-Marseille University, UM 105, Marseille, France., Vey N; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068; CNRS, UMR7258, Institut Paoli-Calmettes; Aix-Marseille University, UM 105, Marseille, France.; Hematology Department, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068; CNRS, UMR7258, Institut Paoli-Calmettes; Aix-Marseille University, UM 105, Marseille, France., Olive D; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068; CNRS, UMR7258, Institut Paoli-Calmettes; Aix-Marseille University, UM 105, Marseille, France.; Immunomonitoring platform, Institut Paoli-Calmettes, Marseille, France.

Publikováno v: Frontiers in immunology [Front Immunol] 2017 May 29; Vol. 8, pp. 573. Date of Electronic Publication: 2017 May 29 (Print Publication: 2017).